Cite
Khan MS, Solomon N, DeVore AD, et al. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. JACC Heart Fail. 2021;doi: 10.1016/j.jchf.2021.11.001.
Khan, M. S., Solomon, N., DeVore, A. D., Sharma, A., Felker, G. M., Hernandez, A. F., Heidenreich, P. A., Matsouaka, R. A., Green, J. B., Butler, J., Yancy, C. W., Peterson, P. N., Fonarow, G. C., & Greene, S. J. (2021). Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. JACC. Heart failure, . https://doi.org/10.1016/j.jchf.2021.11.001
Khan, Muhammad Shahzeb, et al. "Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes." JACC. Heart failure vol. (2021). doi: https://doi.org/10.1016/j.jchf.2021.11.001
Khan MS, Solomon N, DeVore AD, Sharma A, Felker GM, Hernandez AF, Heidenreich PA, Matsouaka RA, Green JB, Butler J, Yancy CW, Peterson PN, Fonarow GC, Greene SJ. Clinical Outcomes With Metformin and Sulfonylurea Therapies Among Patients With Heart Failure and Diabetes. JACC Heart Fail. 2021 Nov 30; doi: 10.1016/j.jchf.2021.11.001. Epub 2021 Nov 30. PMID: 34895861.
Copy
Download .nbib